Showing 1 - 7 results of 7 for search 'Vladimir P Chulanov', query time: 0.03s Refine Results
  1. 1
    Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19

    Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19 by Marina V. Zhuravleva, Vladimir P. Chulanov, Julia V. Gagarina, Elena A. Shabalina

    Published 2023-02-01
    Get full text
    Article
  2. 2
    Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis.

    Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis. by Paul Jülicher, Vladimir P Chulanov, Nikolay N Pimenov, Ekaterina Chirkova, Anna Yankina, Claudio Galli

    Published 2019-01-01
    Get full text
    Article
  3. 3
    Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study

    Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the... by Marina S. Lebedkina, Daria S. Fomina, Zinaida Y. Mutovina, Ulyana A. Mаrkina, Pavel O. Bogomolov, Vladimir P. Chulanov, Mariana A. Lysenko, Ekaterina I. Alexeeva

    Published 2023-08-01
    Get full text
    Article
  4. 4
    The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic

    The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic by Sergey N. Avdeev, Vladimir P. Chulanov, Ekaterina I. Alexeeva, Olga A. Aleshina, Aleksey V. Bereznikov, Oleg N. Kotenko, Aleksander M. Lila, Zinaida Yu. Mutovina, Elena N. Parovichnikova, Daria S. Fomina, Nadiya F. Frolova, Alexey O. Shevchenko

    Published 2023-10-01
    Get full text
    Article
  5. 5
    Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study

    Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study by Artem P. Tkachuk, Evgeniia N. Bykonia, Liubov I. Popova, Denis A. Kleymenov, Maria A. Semashko, Vladimir P. Chulanov, Sergey B. Fitilev, Semyon L. Maksimov, Elena A. Smolyarchuk, Victor A. Manuylov, Daria V. Vasina, Vladimir A. Gushchin, Alexander L. Gintsburg

    Published 2020-11-01
    Get full text
    Article
  6. 6
    Base-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatograms.

    Base-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatograms. by Yuri S Fantin, Alexey D Neverov, Alexander V Favorov, Maria V Alvarez-Figueroa, Svetlana I Braslavskaya, Maria A Gordukova, Inga V Karandashova, Konstantin V Kuleshov, Anna I Myznikova, Maya S Polishchuk, Denis A Reshetov, Yana A Voiciehovskaya, Andrei A Mironov, Vladimir P Chulanov

    Published 2013-01-01
    Get full text
    Article
  7. 7
    Pharmacoepidemiological research of COVID-19 in the Russian Federation EGIDA-2020

    Pharmacoepidemiological research of COVID-19 in the Russian Federation EGIDA-2020 by Natalia Yu. Pshenichnaya, Elena N. Kareva, Irina A. Leneva, Vilya A. Bulgakova, Irina E. Kravchenko, Irina V. Nikolaeva, Antonina I. Grekova, Antonina P. Ivanova, Larisa V. Puzyreva, Guzel M. Khasanova, Svetlana N. Orlova, Elena P. Tikhonova, Vladimir A. Petrov, Oleg V. Malinin, Natalia V. Kolaeva, Elena V. Volchkova, Nina N. Kanshina, Vladimir P. Chulanov

    Published 2021-11-01
    Get full text
    Article

Search Tools: